On June 5th, 2025, The New York Timesfeatured AFAR-affiliated experts Sara Espinoza, MD, MSc, Stephen Kritchevsky, PhD, Dudley Lamming, PhD, and Nathan LeBrasseur, PhD, MS, in an article on exploring factors that can impact biological aging. Each lent insights on science-backed lifestyle interventions, such as exercise and social connectivity, that can help to extend healthspan and delay age-related diseases.
Dr. Espinoza is an AFAR Board Member, a member of the Advisory Committee of the Paul B. Beeson Emerging Leaders Career Development Awards in Aging program of the NIA, and serves as the Co-Chair of the Leadership Core of the Clin-STAR (Clinician-Scientists Transdisciplinary Aging Research) initiative, two initiatives which AFAR helps lead.
Dr. Lamming is a 2015 Glenn Foundation for Medical Research and AFAR Research Grant for Junior Faculty recipient.
Dr. LeBrasseur is a 2002 Glenn/AFAR Scholarship for Research in the Biology of Aging recipient, and the 2019 Vincent Cristofalo Rising Star Award in Aging Researchrecipient.
Dr. Kritchevsky is the Co-Principal Investigator of the Research Centers Collaborative Network (RCCN) of the National Institute of Aging (NIA), which AFAR also manages. Dr. Kritchevsky is also the Principal Investigator of the upcoming AFAR-managed TAME (Targeting Aging with Metformin) Trial.
Read the article “Longevity Hacks for Busy People” in The New York Times here.
